Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bmab 1000 vs. Prolia in Postmenopausal Osteoporosis
NCT05345691Phase 3Completed
- Sponsor
- Biocon
- Start
- May 2022
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
A Phase 3 trial of DenOsteoRel in osteoporosis, sponsored by Biocon. Started May 2022; status: completed.
02
Drugs
DenOsteoRel
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT05345691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05345691.